IP Library Granted Patent US 9,095,165
Granted Patent B2
US 9,095,165 · App. 13/123,374 · Granted Aug 4, 2015

Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient

Inventor: Tohru Tanaka (Saitama, JP)
Assignee: SBI Pharmaceuticals Co., Ltd.
A23L1/3051A23L1/30A23L1/304A23L1/3045A61K31/197A61K31/198A61K31/295A61K31/555A61K33/26A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,165
App. No.
13/123,374
Granted
Aug 4, 2015
Kind
B2
Abstract

It is to provide a pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing/treating an adult disease by using the same. It is to provide a composition for preventing/ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ALA), its derivative, or salt thereof, preferably comprising ALA, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing/ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing/ameliorating an adult disease.

Claims (3)

1. A method for treating an adult disease, comprising administering a composition consisting essentially of 5-aminolevulinic acid (ALA), its ester derivative or acyl derivative, or a salt thereof to a subject in need thereof, wherein adult disease is diabetes.

2. A method for treating an adult disease, comprising administering a composition consisting essentially of (i) 5-aminolevulinic acid (ALA), its ester derivative or acyl derivative, or a salt thereof, and (ii) an iron compound to a subject in need thereof, wherein the adult disease is disease.

3. The method according to claim 2 , wherein the iron compound is one or more compounds selected from the group consisting of ferrous citrate, sodium ferrous citrate, iron sodium citrate, iron ammonium citrate, ferric pyrophosphate, heme iron, iron dextran, iron lactate, ferrous gluconate, DTPA iron, iron sodium diethylenetriaminepentaacetate, iron ammonium diethylenetriaminepentaacetate, iron sodium ethylenediaminetetraacetate, iron ammonium ethylenediaminepentaacetate, iron triethylenetetraamine, iron sodium dicarboxymethylglutamic acid, iron ammonium dicarboxy methylglutamic acid ammonium, lactoferrin iron, transferrin iron, ferric chloride, iron sesquioxide, sodium iron chlorophyllin, ferritin iron, ferrous fumarate, ferrous pyrophosphate, saccharated iron oxide, iron acetate, iron oxalate, ferrous succinate, iron and sodium succinate citrate, iron sulfate, and sulfide glycine iron.

Assignments (2)
CHANGE OF NAME Recorded Feb 25, 2013
From: SBI ALAPROMO CO., LTD.
To: SBI PHARMACEUTICALS CO., LTD.
Reel/Frame 029866/0085 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2011
From: TANAKA, TOHRU
To: SBI ALAPROMO CO., LTD.
Reel/Frame 026097/0391 →
Priority Claims (1)
JP 2008-275914 · Oct 27, 2008 · national
Continuity (1)
Related Publication 20110196033A1 · Aug 11, 2011